The world that we live in is filled with sounds, some are comforting and some could be jarring too. But what if the constant noise surrounding us is doing us more harm than we realize? There has been immense research that shows that noise is not just a nuisance, but a silent killer and affects our health in ways we do not even know. There are associations of sound causing heart attacks, type 2 diabetes, and dementia.

How Does Your Body Respond To Noise?

Noise is seen as an annoyance, but it effects can go beyond what we imagine. When we hear a sound, it travels through the ear to the brain. This is where it gets processed by the amygdala. It is a region that is responsible for emotional responses. This also triggers a stress response- our heart rate increases, our blood pressure rises, and stress hormones like cortisol flood our system.

This response is also designed to help us react to immediate threats. Especially, if we hear the sound of a predator approaching. However, when we are exposed to constant noise, this response is triggered repeatedly and could compel us to live in a long-term anxious state.

Hidden Health Risks

Many studies including Harvard Health and theAmerican College of Cardiology have found associations of noise with health problems including putting a person at a higher risk of cardiovascular diseases such as heart strokes, attacks, and high blood pressure. The constant activation of the stress response can take a toll on the body, increasing inflammation and making it harder for the heart and circulatory system to function properly. Over time, this can lead to serious health conditions like heart disease and diabetes.

Even more troubling, research suggests that noise pollution may contribute to mental health issues. Studies have found a strong connection between exposure to noise and disturbed sleep, which in turn can cause anxiety, depression, and cognitive decline. The World Health Organization estimates that noise contributes to around 12,000 premature deaths annually across Europe alone. This invisible threat, however, is often overlooked because the effects are gradual and cumulative.

Noise and Sleep: A Silent Disturbance

One of the most insidious aspects of noise pollution is its impact on sleep. Even when we are asleep, our bodies are not fully immune to the effects of sound. Our ears never fully “turn off,” meaning that even faint noises can disrupt our sleep cycle. Research has shown that people who live in noisy environments—whether near busy roads, airports, or urban centers—often experience fragmented sleep, leading to fatigue and a weakened immune system. Over time, this chronic lack of restful sleep can lead to significant health problems, including an increased risk of developing cognitive disorders such as dementia.

The Urbanization Problem

As cities continue to grow, noise pollution is becoming more widespread. Traffic noise, in particular, is one of the most common and harmful sources. The rise of urbanization means more cars, buses, and trains, all of which contribute to an ever-increasing din. This urban soundscape is often relentless, with little respite for those living within it. In densely populated cities, people are exposed to high decibel levels, which can exceed safe thresholds for heart health. In many cases, the sheer volume of sound is not just unpleasant; it’s dangerous.

What Can We Do About It?

The solution is not as simple as reducing noise in our immediate surroundings, though efforts to reduce traffic noise and limit industrial sounds are essential. Some cities have taken steps to create quieter spaces by converting busy roads into pedestrian zones or installing noise barriers. These measures have shown to have a positive impact on public health, with research suggesting that even small reductions in noise can prevent premature deaths and improve overall well-being.

If you think that injections of botulinum toxin -- commonly known as Botox -- are only used to make skin wrinkle-free, you may be mistaken.

A new study led by US researchers has shown that Botox injections can act as a “rescue therapy” to treat conditions such as finger ulcers, digital ischemia, and gangrene that are difficult to manage with standard therapies.

Finger ulcers (or digital ulcers) are painful open sores, while acute digital ischemia causes the fingers to become extremely painful, cold, and sometimes pale or bluish in color. Gangrene is the dangerous death of body tissue (necrosis), often turning skin black, green, or purple.

These debilitating complications, often associated with conditions like lupus, rheumatoid arthritis, systemic sclerosis, or bacterial infections, are caused by reduced blood flow to the fingers and heal poorly.

Botox injections, which work by reducing blood vessel constriction and improving circulation, may help achieve complete healing of lesions in more than 85 percent of such patients, according to a study recently published in JAMA Dermatology.

“These new findings are particularly important because therapeutic options remain limited for the cutaneous and vascular manifestations of systemic sclerosis and other autoimmune diseases,” said Dr. Netchiporouk, a scientist in the Infectious Diseases and Immunity in Global Health Program at the Research Institute of the McGill University Health Center.

Netchiporouk noted that the available vasodilator and immunosuppressive treatments are generally administered intravenously.

In contrast to Botox injections, these are also costly, minimally effective, and associated with significant adverse effects.

Also read: Botox Helped Her Burp: How Injectables Changed A 25-Year-Old's Life

The study also described the case of a 50-year-old man with a rare autoimmune disease that caused joint pain and digital necrosis (gangrene).

While traditional medications helped reduce his pain, he was forced to stop working, and the condition severely impacted his quality of life.

However, after receiving botulinum toxin injections, his pain was relieved, and sensation improved within 24 hours, and the necrosis began to improve within two weeks.

“This treatment has become an important tool, especially for patients with autoimmune vascular diseases that result in serious health consequences and for which there are few therapeutic options,” Netchiporouk said.

Also read: Why Regulatory Clarity Is Important for Safe Aesthetic Procedures in India

Botox: Safe, With Minimal Adverse Effects

The study, based on a systematic review and individual patient data meta-analysis of 30 published studies and one unpublished case involving 119 patients, found that only a few patients experienced adverse effects.

These were generally mild and short-lived, most commonly temporary muscle weakness or pain at the injection site.

“Our results show that botulinum toxin can improve blood circulation in the fingers and treat serious complications such as ulcers or gangrene, offering a safe and easy-to-administer alternative,” said Dr. Catherine Zhu, a dermatology resident at the McGill University Health Center.

Zhu added that the injections can be easily administered by rheumatologists and dermatologists in outpatient settings, reducing reliance on intravenous therapies that require hospitalization and increasing overall healthcare costs.

Importantly, in most cases, a single injection session was sufficient to achieve the desired response.

“Botulinum toxin can offer significant benefits with a favorable safety profile. It deserves further study to develop standardized protocols and optimize outcomes,” said Dr. Netchiporouk.

New Delhi: In a world where many are struggling with stress, work pressure, competition at school, and more, it does not come as a shocker that infertility has become too common. Couples often struggle to become parents, and that not only causes emotional stress but also takes a toll on relationships. But thanks to medical advancements, there are procedures like in vitro fertilisation (IVF) that make parenthood possible despite the many curveballs that infertility throws in the way. And with the precision that AI brings to the table, doctors have upped IVF success rates. But in some cases, even vitamin D deficiency can come in the way of a successful IVF treatment.

Read more: The Overlooked Role of Men in IVF: Why Their Silent Strength Is Key to Fertility Success

What is vitamin D deficiency?

Vitamin D, or the sunshine vitamin, is one of the most important nutrients that one needs for a healthy life. It influences mental health, bone and teeth strength, and, as it turns out, fertility as well. An extremely common occurrence in India, it is often seen in women of reproductive age. But can it also affect IVF success rates? Let's find out.

Dr. Kirti Singh, MBBS, MD, DNB (Obs & Gyn), Fellowship in Reproductive Medicine, Clinical Consultant, Aksigen IVF, interacted with Times Now Digital and explained how vitamin D affects women's health.

"Vitamin D is well known for maintaining calcium metabolism and bone health. Apart from that, emerging scientific evidence suggests that vitamin D may influence several pathways relevant to fertility, including ovarian function, endometrial receptivity, hormone regulation, and immune balance within the uterus. Vitamin D receptors (VDRs) are expressed in female reproductive tissues, including the ovaries, uterus, and placenta, hence having a significant impact on female fertility. Vitamin D supplementation has also been shown to have a positive effect on AMH expression. There are studies showing a positive correlation between follicular fluid (vitamin D levels) and fertilization rate. It is also known to regulate the expression of the HOXA10 gene, which helps in implantation," said Dr. Singh.

How does vitamin D deficiency affect fertility in women?

Dr. Nidhi Saluja, Centre Clinical Director, Indira IVF Hospital Limited, Gurugram, said, "Vitamin D deficiency is increasingly being recognised as an important consideration in female reproductive health, including in the context of assisted reproduction. Emerging clinical evidence suggests that low vitamin D is not merely an associated finding in infertility but a factor that may influence how ovaries function, how embryos implant, and how pregnancies progress. Since vitamin D receptors are present in reproductive tissues such as the ovaries, endometrium, and placenta, its role appears to extend beyond bone health into key aspects of fertility and reproductive support."

Read more: What Makes The IVF Journey So Hard On The Mind?

The expert went on to say that this becomes particularly relevant for women undergoing IVF, where factors such as ovarian function, embryo implantation, and endometrial receptivity are all important to treatment outcomes. Evidence suggests that women with sufficient vitamin D levels tend to show better implantation rates, improved embryo quality, and healthier endometrial receptivity. In clinical practice, low vitamin D is also often seen alongside diminished ovarian reserve and suboptimal ovarian response, especially in women already managing hormonal or metabolic challenges.

"Vitamin D status deserves greater attention as part of a comprehensive fertility assessment. While it should not be viewed as the sole determinant of IVF success, it may represent a potentially modifiable factor within broader fertility care. Identifying and addressing deficiency before conception or IVF can therefore help support a more informed and holistic treatment approach, particularly in women facing declining ovarian reserve or complex endocrine profiles," Dr. Saluja added.

What are the best sources of vitamin D?

Our main source of vitamin D, a fat-soluble steroid hormone, is sunlight. Only a small amount is obtained from our diet. In food, it is obtained from natural sources like eggs, fish, mushrooms, cod liver oil, green vegetables, yogurt, and milk. While vitamin D deficiency alone may not be the sole determinant of IVF success, studies increasingly indicate that correcting metabolic and nutritional imbalances can contribute to a healthier reproductive environment.

Even after being preventable and curable, tuberculosis (TB) retains its status as one of the deadliest infectious diseases more than 140 years after Robert Koch announced the discovery of Mycobacterium tuberculosis (Mtb) on March 24, 1882.

A major challenge is that millions of people carry it without knowing, and current tests often miss it. This is known as latent TB infection, where bacteria exist in an inactive state in the body.

While you do not feel sick, the infection can progress to active, contagious TB disease.

Ahead of World Tuberculosis Day, on March 24, scientists at the Indian Council of Medical Research-National Institute for Research in Tuberculosis (NIRT) in Chennai, reported developing an advanced blood test that can find TB even when it's hiding, and before it gets serious.

In the study, published in the Lancet journal eBioMedicine, the researchers explained about detecting circulating cell-free Mtb DNA in the plasma of individuals at high risk of developing TB disease via a dual target-based digital droplet PCR (ddPCR) assay.

The test was targeted at adults without a clear diagnosis of TB (asymptomatic or clinically diagnosed TB).

Using the test, the team led by Luke Elizabeth Hanna from NIRT's Department of Virology and Biotechnology, found TB in the blood up to 18 months before a person was diagnosed.

They identified eight out of 10 people at risk - all before they fell sick with the infectious disease.

“The new test performed better than all existing standard TB tests combined. This test could change how we fight TB - by finding it early, treating it faster, and stopping it from spreading,” said the team in the paper.

Tuberculosis: Advanced Blood Test

Detection of pathogen-derived cell-free DNA (cfDNA) has been gaining much attention in recent years for the diagnosis of several clinical conditions.

cfDNA is a liquid biopsy blood test that analyzes small, non-cellular DNA fragments circulating in the bloodstream.

The team found that the advanced blood test could find tiny traces of TB in the blood - even when a person feels completely healthy.

The test works by breaking a small blood sample into thousands of tiny droplets and searching each one for TB.

The study included 46 healthy household contacts of patients with pulmonary TB who developed TB within two years of follow-up, and 92 HHCs who did not progress to TB.

Plasma was obtained and subjected to testing using a ddPCR assay targeting two Mtb-specific insertion sequences, IS6110 and IS1081.

"Our findings support the diagnostic utility of ddPCR-based detection of circulating Mtb-derived cell-free DNA in plasma of individuals at high risk for progressing to active TB several months prior to clinical diagnosis," the ICMR-NIRT researchers said.

"These findings address important unmet diagnostic needs and indicate the potential of plasma-based Mtb ccfDNA detection to contribute to improved TB case detection and progress towards the WHO End TB goals," they added.

The WHO End TB Strategy

In 2024, an estimated 10.7 million people fell ill with TB worldwide, including 5.8 million men, 3.7 million women and 1.2 million children. TB is present in all countries and age groups, according to the World Health Organization (WHO).

The WHO aims to End TB by 2035, with a 95 percent reduction in deaths and a 90 percent reduction in incidence compared to 2015.